PDSBVSPRME• 7 Days (Normalized)
PDSB vs PRME (PDS Biotechnology Corporation vs Prime Medicine Inc.)
Showing Closing Date Range from Sep, 08 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
PDSB Performance $0.59
+95%
PDS Biotechnology Corporation
Normalized Baseline0.00%
PRME Performance $3.14
-11.8%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin PDSB LEADS
+106.8%
PDSB outperforming by 106.80%
PDSBPRME
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
PDSB PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | PDSB Price | PDSB Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $0.59 | +95.00% | $3.14 | -11.80% | +106.80% |
| Sep 14, 2026 | $0.40 | +33.00% | $3.18 | -10.67% | +43.67% |
| Sep 11, 2026 | $0.30 | -1.67% | $3.13 | -12.08% | +10.41% |
| Sep 10, 2026 | $0.32 | +5.00% | $3.35 | -5.90% | +10.90% |
| Sep 09, 2026 | $0.29 | -2.33% | $3.47 | -2.53% | +0.20% |
| Sep 08, 2026 | $0.30 | +0.00% | $3.56 | +0.00% | +0.00% |